Celestica, Inc. (CLS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Celestica (CLS). This makes it worthwhile to examine what the stock has in store.
Celestica (CLS) Suffers a Larger Drop Than the General Market: Key Insights
Celestica (CLS) concluded the recent trading session at $93.82, signifying a -1.35% move from its prior day's close.
Celestica: A Trifecta Of Growth, Margin Expansion And Improving Cash Flow Conversion
The growth outlook is strong, driven by tailwinds in the CCS segments' end markets. The mix-shift driven EBIT margin thesis is playing out and has more runway as the higher-margin CCS is expected to continue outgrowing ATS. Inventory reduction is improving net working capital intensity, which can lead to a higher base of FCF conversion.
Wall Street Bulls Look Optimistic About Celestica (CLS): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Celestica (CLS) Advances While Market Declines: Some Information for Investors
Celestica (CLS) concluded the recent trading session at $93.05, signifying a +1.02% move from its prior day's close.
Celestica, Inc. (CLS) Is a Trending Stock: Facts to Know Before Betting on It
Celestica (CLS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Celestica, Inc. (CLS) Hit a 52 Week High, Can the Run Continue?
Celestica (CLS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Celestica: Management Guidance Appears Very Conservative
Celestica's stock surged 45.81% since my last article, driven by a significant EPS and revenue beat, reinforcing my strong buy recommendation. The CCS segment's rapid growth and higher margins are key drivers, contributing to firm-level revenue and EPS expansion. Management's conservative 2025 outlook is likely understated, with analysts buying into this narrative.
CLS Stock Trades Near 52-Week High: Is There More Room to Run?
Riding on a robust earnings surprise history and favorable Zacks Rank, CLS appears primed for further stock price appreciation.
Celestica Could Be Tremendously Undervalued As Pressures Grow On Supply Chains
Celestica has been able to build a commanding position across a range of key sectors in recent years, supporting a Buy rating. Strong growth in earnings, a robust balance sheet, and tactical investments in technology set the company apart from competitors. After a tremendous rally in recent years, I still see further growth as sectors continue to surge.
Celestica: 2025 Should Look Much Different
Celestica's stock has surged, tripling in value over eleven months, but short-term upside appears limited due to overextended daily price charts and negative momentum divergence. Despite overbought conditions, long-term fundamentals remain strong, with impressive EPS growth driven by operating leverage and share repurchases, though margin expansion may slow. Valuation concerns arise as Celestica's stock trades at 21X forward earnings, limiting multiple expansion potential and suggesting more muted expectations for 2025.
Investors Heavily Search Celestica, Inc. (CLS): Here is What You Need to Know
Celestica (CLS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
